An Improved Reverse Genetics System to Overcome Cell-Type-Dependent Ebola Virus Genome Plasticity.

Yoshimi Tsuda, Thomas Hoenen, Logan Banadyga, Carla Weisend, Stacy M Ricklefs, Stephen F Porcella, Hideki Ebihara
Author Information
  1. Yoshimi Tsuda: Molecular Virology and Host-Pathogen Interaction Unit Department of Microbiology, Graduate School of Medicine, Hokkaido University, Sapporo, Japan.
  2. Thomas Hoenen: Disease Modeling and Transmission Section, Laboratory of Virology.
  3. Logan Banadyga: Molecular Virology and Host-Pathogen Interaction Unit.
  4. Carla Weisend: Molecular Virology and Host-Pathogen Interaction Unit.
  5. Stacy M Ricklefs: Genomics Unit, Research Technology Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
  6. Stephen F Porcella: Genomics Unit, Research Technology Section, Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana.
  7. Hideki Ebihara: Molecular Virology and Host-Pathogen Interaction Unit.

Abstract

Reverse genetics systems represent a key technique for studying replication and pathogenesis of viruses, including Ebola virus (EBOV). During the rescue of recombinant EBOV from Vero cells, a high frequency of mutations was observed throughout the genomes of rescued viruses, including at the RNA editing site of the glycoprotein gene. The influence that such genomic instability could have on downstream uses of rescued virus may be detrimental, and we therefore sought to improve the rescue system. Here we report an improved EBOV rescue system with higher efficiency and genome stability, using a modified full-length EBOV clone in Huh7 cells. Moreover, by evaluating a variety of cells lines, we revealed that EBOV genome instability is cell-type dependent, a fact that has significant implications for the preparation of standard virus stocks. Thus, our improved rescue system will have an impact on both basic and translational research in the filovirus field.

Keywords

References

  1. J Virol. 2011 Jun;85(11):5406-14 [PMID: 21411529]
  2. Lancet. 2011 Mar 5;377(9768):849-62 [PMID: 21084112]
  3. J Infect Dis. 2011 Nov;204 Suppl 3:S934-40 [PMID: 21987772]
  4. J Infect Dis. 2011 Nov;204 Suppl 3:S941-6 [PMID: 21987773]
  5. J Virol. 2012 Nov;86(21):11779-88 [PMID: 22915810]
  6. PLoS One. 2012;7(11):e50316 [PMID: 23209706]
  7. PLoS Pathog. 2013;9(10):e1003677 [PMID: 24146620]
  8. Virology. 1999 Oct 25;263(2):364-75 [PMID: 10544109]
  9. J Virol. 2000 Oct;74(19):9245-55 [PMID: 10982372]
  10. Science. 2001 Mar 9;291(5510):1965-9 [PMID: 11239157]
  11. J Virol. 2002 Jan;76(1):406-10 [PMID: 11739705]
  12. Microbiol Immunol. 2003;47(8):613-7 [PMID: 14524622]
  13. Curr Top Microbiol Immunol. 2004;283:1-41 [PMID: 15298166]
  14. Virology. 1995 Dec 20;214(2):421-30 [PMID: 8553543]
  15. Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3602-7 [PMID: 8622982]
  16. J Virol. 1999 Mar;73(3):2333-42 [PMID: 9971816]
  17. J Infect Dis. 1999 Feb;179 Suppl 1:S177-87 [PMID: 9988182]
  18. J Virol. 2005 Feb;79(4):2413-9 [PMID: 15681442]
  19. Microbes Infect. 2005 Jun;7(7-8):1005-14 [PMID: 16002313]
  20. Thromb Haemost. 2005 Aug;94(2):240-53 [PMID: 16113812]
  21. Microbes Infect. 2006 May;8(6):1522-9 [PMID: 16697679]
  22. PLoS Pathog. 2006 Jul;2(7):e73 [PMID: 16848640]
  23. Virology. 2010 Jul 20;403(1):56-66 [PMID: 20444481]
  24. Antiviral Res. 2011 Aug;91(2):195-208 [PMID: 21699921]

Grants

  1. /Intramural NIH HHS

MeSH Term

Animals
COS Cells
Cell Line
Cell Line, Tumor
Chlorocebus aethiops
Ebolavirus
Genome, Viral
Genomic Instability
Glycoproteins
HEK293 Cells
Hemorrhagic Fever, Ebola
Humans
Mutation
Reverse Genetics
Vero Cells
Virus Replication

Chemicals

Glycoproteins

Word Cloud

Created with Highcharts 10.0.0EBOVvirusrescuesystemEbolacellsReversegeneticsvirusesincludingrescuedRNAeditingsiteinstabilityimprovedgenomesystemsrepresentkeytechniquestudyingreplicationpathogenesisrecombinantVerohighfrequencymutationsobservedthroughoutgenomesglycoproteingeneinfluencegenomicdownstreamusesmaydetrimentalthereforesoughtimprovereporthigherefficiencystabilityusingmodifiedfull-lengthcloneHuh7Moreoverevaluatingvarietylinesrevealedcell-typedependentfactsignificantimplicationspreparationstandardstocksThuswillimpactbasictranslationalresearchfilovirusfieldImprovedGeneticsSystemOvercomeCell-Type-DependentVirusGenomePlasticitymutationreverse

Similar Articles

Cited By